Dr Chris Wincup asks Dr Filipa Farinha (London, UK) about her recent paper, which compares presentation, outcomes and predictors of survival in patients with membranous and proliferative lupus nephritis. They discuss the key findings, important implications for clinical practice, and Dr Farinha’s future research ..read more

Dr Marwan Bukhari asks Dr Neil Basu (Glasgow, UK) about his recent paper. Using data from the BSRBR-AS, the study aimed to quantify and predict the effect of anti-TNF therapy on axSpA-related fatigue. This paper is the Editor’s Choice for November ..read more

Dr Richard Conway (Dublin, Ireland) and Dr Elena Nikiphorou (London, UK) interview Dr Carlos Fernández-Díaz (Santander, Spain) about his recent paper, which examines the efficacy of abatacept in interstitial lung disease associated with rheumatoid arthritis. Their discussion includes the study’s key learning points, how this research may influence clinical practice, and future research plans ..read more

Dr Marwan Bukhari asks Dr William Tillett (Bath, UK) and Dr Laura Coates (Oxford, UK) about the upcoming BSR psoriatic arthritis guideline. They explain why a new guideline is needed, how it will differ from others, and also offer some insight into the scope, which will consider PsA domains, comorbidities, therapy selection, and treatment strategies ..read more

Dr Mrinalini Dey asks Dr Deva Situnayake (Birmingham, UK) about his recent paper, in which a primary care database was used to examine epidemiology, morbidity and mortality in Behçet’s disease in the UK. Dr Situnayake identifies the study’s key findings, including the increasing prevalence of Behçet’s, as well as recommendations for clinical practice ..read more

Dr Steven Zhao asks Dr Lewis Carpenter (King’s College London, UK) about his recent paper, which found that improvements in early RA clinical markers were not translated into similar improvements in patient-reported outcomes. They highlight the necessity of holistic treatment to manage pain, fatigue and mental health, as well as the importance of multidisciplinary teams in clinical practice ..read more

Dr Chris Wincup asks Dr Md Yuzaiful Md Yusof (Leeds, UK) about his recent paper, which examines the effect of rituximab and TNF inhibitors on lung infection and survival in RA-associated bronchiectasis. They discuss the study’s aims, design and main findings, as well as key messages for clinicians ..read more

Dr Mrinalini Dey asks Dr Kathrine Grøn (Copenhagen, Denmark) about her recent paper, which examines infection risk in RA patients treated with abatacept, rituximab and tocilizumab. They discuss the DANBIO cohort, the differences in incidence rates between biologic-naïve patients and switchers, and also consider the results in the context of COVID-19. This paper is the Editor’s Choice for August 2020 ..read more

Dr Steven Zhao and Dr Cristina Maglio (University of Gothenburg, Sweden) discuss her recent paper - the third in a series exploring the effect of bariatric surgery on rheumatic disease risk. They consider the paper’s key findings, implications for clinical practice, and why bariatric surgery impacts rheumatoid arthritis, gout and psoriatic arthritis differently ..read more

Dr Chris Wincup talks to Dr Elena Nikiphorou (King's College London, UK) about her recent review article, which examines the current evidence for methotrexate-associated interstitial lung disease in patients with rheumatoid arthritis. They discuss th ..read more